Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 25.06
-1.64 (-6.14%)
Jul 29, 2026, 3:00 PM CST
SHA:603538 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,564 | 1,503 | 1,373 | 1,216 | 1,457 | 1,258 |
Revenue Growth | 12.82% | 9.49% | 12.85% | -16.51% | 15.80% | 5.43% |
Gross Profit Gross Profit Growth | 494.71 | 490 | 421.28 | 342.71 | 566.16 | 465.93 |
Operating Income Operating Income Growth | 160.07 | 149.11 | 93.47 | 26.36 | 205.4 | 169.94 |
Net Income Net Income Growth | 112.17 | 102.23 | 66.81 | 11.59 | 338.86 | 142.53 |
Earnings Per Share EPS Growth | 0.36 | 0.34 | 0.22 | 0.04 | 1.06 | 0.48 |
EPS Growth | 47.63% | 51.63% | 520.17% | -96.65% | 122.38% | -11.70% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Intermediates and Raw Materials Intermediates and Raw Materials Growth | 769 |
CDMO CDMO Growth | 84.1 |
Preparations Preparations Growth | 611.9 |
Trade Trade Growth | 26.08 |
Total Total Growth | 1,491 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 641.51 | 918.49 | 739.87 | 724.69 | 1,009 | 793.16 |
Total Debt Total Debt Growth | 1,307 | 1,503 | 1,342 | 1,302 | 1,203 | 1,260 |
Net Cash (Debt) Net Cash Growth | -665.29 | -584.26 | -601.66 | -577.77 | -193.29 | -467.21 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.12 | -1.92 | -1.99 | -1.78 | -0.61 | -1.57 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 156.86 | 157.56 | 97.54 | 9.13 | 276.95 | 220.63 |
Capital Expenditures CapEx Growth | -128.91 | -112.08 | -179.4 | -219.54 | -571.62 | -529.89 |
Free Cash Flow Free Cash Flow Growth | 27.96 | 45.48 | -81.87 | -210.41 | -294.67 | -309.26 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.62% | 32.60% | 30.69% | 28.17% | 38.86% | 37.03% |
Operating Margin | 10.23% | 9.92% | 6.81% | 2.17% | 14.10% | 13.51% |
Pretax Margin | 8.82% | 8.63% | 6.33% | 0.65% | 26.37% | 14.33% |
Profit Margin | 7.17% | 6.80% | 4.87% | 0.95% | 23.26% | 11.33% |
FCF Margin | 1.79% | 3.03% | -5.96% | -17.30% | -20.22% | -24.58% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.111 | 0.111 | 0.036 | 0.014 | 0.118 | 0.102 |
Dividend Per Share Growth | 334.05% | 210.08% | 149.65% | -87.87% | 16.16% | - |
Dividend Yield | 0.41% | 0.81% | 0.40% | 0.11% | 0.65% | 0.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 70.17 | 41.52 | 41.62 | 352.19 | 16.22 | 37.27 |
Forward PE | - | 27.68 | 13.31 | 23.46 | 18.90 | 24.70 |
P/FCF Ratio | 304.72 | 93.33 | - | - | - | - |
PS Ratio | 5.45 | 2.82 | 2.03 | 3.35 | 3.77 | 4.22 |